loading page

OUTCOMES OF COVID-19 INFECTIONS IN CHILDREN: A SINGLE-CENTER RETROSPECTIVE STUDY
  • +4
  • MUSTAFA GENÇELİ,
  • Ozge Metin Akcan,
  • Sevgi Pekcan,
  • Fatih Akın,
  • Mehmet Özdemir,
  • Ahmet Osman KILIÇ,
  • Abdullah Yazar
MUSTAFA GENÇELİ
Necmettin Erbakan University Meram Medical Faculty Hospital

Corresponding Author:[email protected]

Author Profile
Ozge Metin Akcan
Necmettin Erbakan University Meram Medical Faculty Hospital
Author Profile
Sevgi Pekcan
Meram Medical Faculty
Author Profile
Fatih Akın
Necmettin Erbakan University Meram Medical Faculty Hospital
Author Profile
Mehmet Özdemir
Necmettin Erbakan University Meram Medical Faculty Hospital
Author Profile
Ahmet Osman KILIÇ
Necmettin Erbakan University Meram Medical Faculty Hospital
Author Profile
Abdullah Yazar
Necmettin Erbakan University Meram Medical Faculty Hospital
Author Profile

Abstract

Objective: The COVID-19 pandemic is an important cause of morbidity and mortality, which has had a negative impact worldwide. Our aim was to describe clinical findings and outcomes of SARS-CoV-2 viral infection and Covid-19 disease cared for at a large pediatric tertiary care hospital during the first year of the pandemic. Methods: Patients aged 1 month to 18 years who were diagnosed as having COVID-19 between March 2020 and April 2021 were included. The files of patients diagnosed with covid-19 were reviewed retrospectively. Results: 467 children were included in the study. There were 34 (7.3%) patients under one year of age, 111 (23.8%) between 1-5 years, 98 (30.4%) between 5-10 years, 142 (30.4%) between 11-15 years, and 82 (17.6%) age over 15 years. Fever (88.2%), vomiting (32.4%), and diarrhea (29.4%) in patients aged under 1 year, sore throat (36.6%) in patients aged 11-15 years, and dysgeusia (11%), anosmia (14.6%), headache (18.3%), malaise (40.8%), myalgia (28%), and dyspnea (17.1%) in those aged over 15 years of age were found significantly more common compared with the other age groups (p<0.05). Thirty-five (7.5%) patients were asymptomatic, 365 (78.1%) had mild disease, 35 (7.5%) were moderate, 27 (5.8%) were severe, and five (1.07%) were critical. Leukocyte count, erythrocyte sedimentation rate, ferritin, and C-reactive protein values were significantly higher in hospitalized patients. Four patients died during the study period (0.8%, 4/467). Conclusion: While SARS-CoV-2 infection may be asymptomatic and Covid-19 disease usually has a mild clinical course, some children have severe disease or mortality.
26 Oct 2021Submitted to Pediatric Pulmonology
27 Oct 2021Submission Checks Completed
27 Oct 2021Assigned to Editor
28 Oct 2021Reviewer(s) Assigned
23 Nov 2021Review(s) Completed, Editorial Evaluation Pending
26 Nov 2021Editorial Decision: Revise Major
21 Feb 20221st Revision Received
22 Feb 2022Submission Checks Completed
22 Feb 2022Assigned to Editor
22 Feb 2022Reviewer(s) Assigned
20 Mar 2022Review(s) Completed, Editorial Evaluation Pending
28 Mar 2022Editorial Decision: Revise Minor
16 Apr 20222nd Revision Received
18 Apr 2022Submission Checks Completed
18 Apr 2022Assigned to Editor
18 Apr 2022Reviewer(s) Assigned
27 Apr 2022Review(s) Completed, Editorial Evaluation Pending
27 Apr 2022Editorial Decision: Revise Minor
29 Apr 20223rd Revision Received
02 May 2022Submission Checks Completed
02 May 2022Assigned to Editor
02 May 2022Reviewer(s) Assigned
08 May 2022Review(s) Completed, Editorial Evaluation Pending
28 May 2022Editorial Decision: Revise Minor
01 Jun 20224th Revision Received
02 Jun 2022Submission Checks Completed
02 Jun 2022Assigned to Editor
03 Jun 2022Review(s) Completed, Editorial Evaluation Pending
08 Jun 2022Editorial Decision: Revise Minor
11 Jun 20225th Revision Received
17 Jun 2022Submission Checks Completed
17 Jun 2022Assigned to Editor
23 Jun 2022Review(s) Completed, Editorial Evaluation Pending
23 Jun 2022Editorial Decision: Revise Minor
25 Jun 20226th Revision Received
05 Jul 2022Submission Checks Completed
05 Jul 2022Assigned to Editor
06 Jul 2022Review(s) Completed, Editorial Evaluation Pending
07 Jul 2022Editorial Decision: Accept
03 Aug 2022Published in Pediatric Pulmonology. 10.1002/ppul.26070